H. D. Winter

发表

Properties of Oligonucleotides with Six Membered Carbohydrate Mimics and a 1,4-Relationship Between the Base Moiety and the Hydroxymethyl Group

P. Herdewijn, A. Aerschot, B. Allart, 1999 .

Synthesis of 3′-Deoxy-3′-C-Hydroxymethyl-aldopentopyranosyl Nucleosides and their Incorporation in Oligonucleotides. Part II 1.

P. Herdewijn, A. Aerschot, H. D. Winter, 1995 .

Aldose reductase as a target for drug design: molecular modeling calculations on the binding of acyclic sugar substrates to the enzyme.

M. Itzstein, H. D. Winter, 1995 .

Design and molecular modelling of antisense pyranosyl oligonucleotides

N. Blaton, O. Peeters, C. J. Ranter, 1993 .

Structure of 1-(2-deoxy-β-D-ribopyranosyl)-5-iodouracil

P. Herdewijn, A. Aerschot, N. Blaton, 1991 .

Structure of the antiviral drug ethyl 4-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}benzoate

N. Blaton, O. Peeters, C. J. Ranter, 1991 .

2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.

Junya Qu, Allen B Reitz, Brett A Tounge, 2007, Journal of medicinal chemistry.

Synthesis of 2′‐Deoxy‐5‐(isothiazol‐5‐yl)uridine and Its Interaction with the HSV‐1 Thymidine Kinase

P. Herdewijn, R. Busson, I. Luyten, 1996 .

Hexopyranosyl-like oligonucleotides

P. Herdewijn, A. Aerschot, K. Augustyns, 1994 .

Conformational Analysis, Solvent-Accessible Surface and Geometric Extent of Inhibitors and Substrates

P. Herdewijn, M. Froeyen, H. D. Winter, 2006 .

Structure of 1‐(2‐deoxy‐2‐fluoro‐α‐d‐arabinopyranosyl)‐5‐iodouracil

P. Herdewijn, A. Aerschot, N. Blaton, 1991 .

Conformational properties of pyranosyl nucleosides by X-ray diffraction and modelling techniques

N. Blaton, O. Peeters, C. J. Ranter, 1993 .

Structures of 1-(2,3-dideoxy-erythro-α-D-hexopyranosyl)thymine and the 1-(2,3-dideoxy-erythro-β-D-hexopyranosyl)thymine.dioxane complex

P. Herdewijn, A. Aerschot, N. Blaton, 1991 .

1-(2,3-Dideoxy-erythro-β-d-hexopyranosyl)cytosine: an example of the conformational and stacking properties of pyranosyl pyrimidine nucleosides. A crystallographic and computational approach

P. Herdewijn, A. Aerschot, N. Blaton, 1992 .

Structure of the Neuroleptic Drug N-((1-Allyl-2-pyrrolidinyl)methyl)-6-methoxy-1H-benzotriazole-5-carboxamide Hydrochloride (Alizapride)

N. Blaton, O. Peeters, C. J. Ranter, 1990 .

Structure of the neuroleptic drug N‐[(1‐allyl‐2‐pyrrolidinyl)methyl]‐6‐methoxy‐1H‐benzotriazole‐5‐carboxamide hydrochloride (alizapride)

N. Blaton, O. Peeters, C. J. Ranter, 1990 .